Taking advantage of genomics technology, especially the advances of scRNA-seq in recent decades, relevant studies could be designed to confirm the role of the PD-1/PD-L1 axis in IPF, identify the involved cell populations, and clarify the underlying regulatory mechanisms. Here, RPL17 is linked to idiopathic pulmonary fibrosis.